Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables.

[1]  O. Ural,et al.  Serum annexin A2 levels in acute brucellosis and brucellar spondylodiscitis , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[2]  Chiou-Feng Lin,et al.  Annexin A2: Its Molecular Regulation and Cellular Expression in Cancer Development , 2014, Disease markers.

[3]  Haiyang Xie,et al.  Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis , 2013, Oncology letters.

[4]  K. Hajjar,et al.  Annexin A2 System in Human Biology: Cell Surface and Beyond , 2013, Seminars in Thrombosis & Hemostasis.

[5]  Qi Zhang,et al.  Upregulated expression of Annexin II is a prognostic marker for patients with gastric cancer , 2012, World Journal of Surgical Oncology.

[6]  C. Giacomantonio,et al.  Annexin A2 is a novel Cellular Redox Regulatory Protein involved in Tumorigenesis , 2011, Oncotarget.

[7]  R. Layfield,et al.  Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy. , 2009, European journal of cancer.

[8]  M. Miyazaki,et al.  Annexin II Overexpression Predicts Rapid Recurrence after Surgery in Pancreatic Cancer Patients Undergoing Gemcitabine-Adjuvant Chemotherapy , 2008, Annals of surgical oncology.

[9]  J. Bai,et al.  Involvement of Annexin A2 in p53 induced apoptosis in lung cancer , 2008, Molecular and Cellular Biochemistry.

[10]  Pomila Singh.  Role of Annexin-II in GI cancers: interaction with gastrins/progastrins. , 2007, Cancer letters.

[11]  Y. Nakajima,et al.  Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. , 2001, Anticancer research.

[12]  Bonnie F. Sloane,et al.  Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. , 2000, Biochimica et biophysica acta.